Literature DB >> 1639841

PDGF-AA and PDGF-BB biosynthesis: proprotein processing in the Golgi complex and lysosomal degradation of PDGF-BB retained intracellularly.

A Ostman1, J Thyberg, B Westermark, C H Heldin.   

Abstract

Platelet-derived growth factor is a potent mitogen for cells of mesenchymal origin. It is made up of two polypeptide chains (A and B) combined in three disulfide-linked dimeric forms (AA, AB, and BB). Here, the biosynthesis and proteolytic processing of the two homodimeric forms of PDGF (AA and BB) were studied in CHO cells stably transfected with A-chain (short splice version) or B-chain cDNA. PDGF-AA was processed to a 30-kD molecule which was secreted from the cells. In contrast, PDGF-BB formed two structurally distinct end products; a minor secreted 30-kD form and a major cell-associated 24-kD form. Immunocytochemical studies at light- and electron-microscopical levels revealed presence of PDGF in the Golgi complex, in lysosomes, and to a smaller extent in the ER. From analysis of cells treated with brefeldin A, an inhibitor of ER to Golgi transport, it was concluded that dimerization occurs in the ER, whereas the proteolytic processing of PDGF-AA and PDGF-BB precursors normally occurs in a compartment distal to the ER. Exposure of the cultures to the lysosomal inhibitor chloroquine led to an increased cellular accumulation of PDGF-BB, as determined both by metabolic labeling experiments and immunocytochemical methods, indicating that the retained form of PDGF-BB is normally degraded in lysosomes. Structural analysis of the two end products of PDGF-BB revealed that the secreted 30-kD form is a dimer of peptides processed as the B-chain of PDGF purified from human platelets, and that the retained 24-kD form is made up of subunits additionally processed in the NH2-terminus. Also, the 24-kD form was shown to be composed of proteolytic fragments held together by disulfide bridges. Taken together these findings suggest that the newly synthesized PDGF A- and B-chains are dimerized in the ER and thereafter transferred to the Golgi complex for proteolytic processing. From there, PDGF-AA is carried in vesicles to the cell surface for release extracellularly by exocytosis. A smaller part of PDGF-BB (the 30-kD form) is handled in a similar way, whereas the major part (the 24-kD form) is generated by additional proteolysis in the Golgi complex, from which it is slowly carried over to lysosomes for degradation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639841      PMCID: PMC2289541          DOI: 10.1083/jcb.118.3.509

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  31 in total

1.  A novel mechanism regulating growth factor association with the cell surface: identification of a PDGF retention domain.

Authors:  W J LaRochelle; M May-Siroff; K C Robbins; S A Aaronson
Journal:  Genes Dev       Date:  1991-07       Impact factor: 11.361

2.  Proteolytic processing of a plasma membrane-bound precursor to human macrophage colony-stimulating factor (CSF-1) is accelerated by phorbol ester.

Authors:  J Stein; C W Rettenmier
Journal:  Oncogene       Date:  1991-04       Impact factor: 9.867

Review 3.  Platelet-derived growth factor: mechanism of action and possible in vivo function.

Authors:  C H Heldin; B Westermark
Journal:  Cell Regul       Date:  1990-07

4.  Expression of recombinant platelet-derived growth factor A- and B-chain homodimers in rat-1 cells and human fibroblasts reveals differences in protein processing and autocrine effects.

Authors:  M Bywater; F Rorsman; E Bongcam-Rudloff; G Mark; A Hammacher; C H Heldin; B Westermark; C Betsholtz
Journal:  Mol Cell Biol       Date:  1988-07       Impact factor: 4.272

5.  Cleavage of the membrane precursor for transforming growth factor alpha is a regulated process.

Authors:  A Pandiella; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

6.  Expression of three recombinant homodimeric isoforms of PDGF in Saccharomyces cerevisiae: evidence for difference in receptor binding and functional activities.

Authors:  A Ostman; G Bäckström; N Fong; C Betsholtz; C Wernstedt; U Hellman; B Westermark; P Valenzuela; C H Heldin
Journal:  Growth Factors       Date:  1989       Impact factor: 2.511

7.  Identification of a cell retention signal in the B-chain of platelet-derived growth factor and in the long splice version of the A-chain.

Authors:  A Ostman; M Andersson; C Betsholtz; B Westermark; C H Heldin
Journal:  Cell Regul       Date:  1991-07

8.  Novel purification of the catalytic domain of Golgi alpha-mannosidase II. Characterization and comparison with the intact enzyme.

Authors:  K W Moremen; O Touster; P W Robbins
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

9.  Localization of platelet-derived growth factor (PDGF) in CHO cells transfected with PDGF A- or B-chain cDNA: retention of PDGF-BB in the endoplasmic reticulum and Golgi complex.

Authors:  J Thyberg; A Ostman; G Bäckström; B Westermark; C H Heldin
Journal:  J Cell Sci       Date:  1990-10       Impact factor: 5.285

Review 10.  Brefeldin A: insights into the control of membrane traffic and organelle structure.

Authors:  R D Klausner; J G Donaldson; J Lippincott-Schwartz
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

View more
  16 in total

1.  Divergent fates of P- and E-selectins after their expression on the plasma membrane.

Authors:  M Subramaniam; J A Koedam; D D Wagner
Journal:  Mol Biol Cell       Date:  1993-08       Impact factor: 4.138

2.  Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas.

Authors:  Nobuhiro Hata; Naoki Shinojima; Joy Gumin; Raymund Yong; Frank Marini; Michael Andreeff; Frederick F Lang
Journal:  Neurosurgery       Date:  2010-01       Impact factor: 4.654

3.  Endothelial platelet-derived growth factor-mediated activation of smooth muscle platelet-derived growth factor receptors in pulmonary arterial hypertension.

Authors:  Kang Wu; Haiyang Tang; Ruizhu Lin; Shane G Carr; Ziyi Wang; Aleksandra Babicheva; Ramon J Ayon; Pritesh P Jain; Mingmei Xiong; Marisela Rodriguez; Shamin Rahimi; Francesca Balistrieri; Shayan Rahimi; Daniela Valdez-Jasso; Tatum S Simonson; Ankit A Desai; Joe G N Garcia; John Y-J Shyy; Patricia A Thistlethwaite; Jian Wang; Ayako Makino; Jason X-J Yuan
Journal:  Pulm Circ       Date:  2020-09-10       Impact factor: 3.017

4.  A precursor form of vascular endothelial growth factor arises by initiation from an upstream in-frame CUG codon.

Authors:  M K Tee; R B Jaffe
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

5.  Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).

Authors:  M G Achen; M Jeltsch; E Kukk; T Mäkinen; A Vitali; A F Wilks; K Alitalo; S A Stacker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

6.  An oncogenic activity of PDGF-C and its splice variant in human breast cancer.

Authors:  Alyssa Bottrell; Yong Hong Meng; Abdo J Najy; Newton Hurst; Seongho Kim; Chong Jai Kim; Eun-Sook Kim; Aree Moon; Eun Joo Kim; So Yeon Park; Hyeong-Reh Choi Kim
Journal:  Growth Factors       Date:  2019-09-23       Impact factor: 2.511

7.  Effects of secreted factors in culture medium of annulus fibrosus cells on microvascular endothelial cells: elucidating the possible pathomechanisms of matrix degradation and nerve in-growth in disc degeneration.

Authors:  H J Moon; T Yurube; T P Lozito; P Pohl; R A Hartman; G A Sowa; J D Kang; N V Vo
Journal:  Osteoarthritis Cartilage       Date:  2013-12-18       Impact factor: 6.576

8.  Tissue plasminogen activator is a potent activator of PDGF-CC.

Authors:  Linda Fredriksson; Hong Li; Christina Fieber; Xuri Li; Ulf Eriksson
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

9.  Lysophosphatidic acid possesses dual action in cell proliferation.

Authors:  G Tigyi; D L Dyer; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

10.  A novel human c-sis mRNA species is transcribed from a promoter in c-sis intron 1 and contains the code for an alternative PDGF B-like protein.

Authors:  R P Dirks; C Onnekink; H J Jansen; A de Jong; H P Bloemers
Journal:  Nucleic Acids Res       Date:  1995-08-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.